Reckitt Benckiser, Abbot, Business, Healthcare industry, Children’s health Business | The Guardian
British group says claims products cause serious bowel condition NEC are ‘not supported by science’ Reckitt Benckiser’s share price has dropped to a 10-year low after a US court ruled that a formula produced by rival Abbott Laboratories had caused a baby girl to develop a serious bowel disease.Shares in the British consumer goods group, which is facing similar legal action over its Enfamil formula, saw its shares plunge by about 9% to roughly £40.75 a share on Monday after Abbott was ordered to pay $495m (£385m) in damages by a court in Missouri on Friday. Continue reading…
British group says claims products cause serious bowel condition NEC are ‘not supported by science’
Reckitt Benckiser’s share price has dropped to a 10-year low after a US court ruled that a formula produced by rival Abbott Laboratories had caused a baby girl to develop a serious bowel disease.
Shares in the British consumer goods group, which is facing similar legal action over its Enfamil formula, saw its shares plunge by about 9% to roughly £40.75 a share on Monday after Abbott was ordered to pay $495m (£385m) in damages by a court in Missouri on Friday.
